Researchers have found that patients with coronary artery disease (CAD) who had transitioned entirely to e-cigarettes or quit ...

In an attempt to reduce ischemic events during and after percutaneous coronary intervention (PCI), an intensive antiplatelet and anticoagulant regimen has been adopted. The trade-off of this ...

Patients who suffer a GI bleed after PCI are a challenging group. They may have multiple comorbidities and are often medically unstable; treatment must balance the need to prevent ischemic post ...

Despite angiographically successful primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction, microcirculatory failure is common and leads to an ...

TCT 452: Angio-Based Quantitative Fractional Ratio After Drug-Coated Balloon for De Novo Coronary Lesions: Potential Role of Single View-Based Analysis Receive the the latest news, research, and ...

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

Stent thrombosis is a rare but potentially life threatening complication of percutaneous coronary intervention (PCI). It develops when a blood clot blocks blood flow through your stent.

AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS ...

Supira Medical began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD ...